Crizotinib in ROS1 rearranged or MET deregulated non-small-cell lung cancer (NSCLC): final results of the METROS trial

L. Landi, R. Chiari, C. Dazzi, M. Tiseo, A. Chella, A. Delmonte, L. Bonanno, D. Cortinovis, F. de Marinis, G. Minuti, R. Buosi, A. Morabito, P. Maione, D. Galetta, F. Barbieri, F. Grossi, S. Novello, R. Bruno, G. Fontanini, L. CrinòF. Cappuzzo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)vi54
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - Oct 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this